BLINCOREST125MG30TAB

Blincorest 125mg is a pharmaceutical product containing Palbociclib, a kinase inhibitor used primarily in the treatment of certain types of breast cancer. It works by inhibiting cyclin-dependent kinases (CDK4 and CDK6), which are proteins that promote cell division and tumor growth. This medication is typically prescribed as part of a comprehensive oncology treatment plan, often in combination with hormonal therapies. It is essential that this medication is administered under the strict supervision of an oncologist, following a personalized treatment protocol based on the patient's specific medical history and diagnostic results.